Healthcare - Biotechnology - NASDAQ - US
$ 2.61
-6.79 %
$ 43.9 M
Market Cap
-0.61
P/E
BALANCE SHEET
74.9 M
ASSETS
49.3 M
LIABILITIES
25.6 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
OncoCyte Corporation
| Current Assets | 10.7 M |
| Cash & Short-Term Investments | 9.43 M |
| Receivables | 484 K |
| Other Current Assets | 782 K |
| Non-Current Assets | 64.2 M |
| Long-Term Investments | 0 |
| PP&E | 5.44 M |
| Other Non-Current Assets | 58.8 M |
| Current Liabilities | 7.19 M |
| Accounts Payable | 953 K |
| Short-Term Debt | 1.33 M |
| Other Current Liabilities | 4.91 M |
| Non-Current Liabilities | 42.1 M |
| Long-Term Debt | 2.2 M |
| Other Non-Current Liabilities | 39.9 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Cash & Cash Equivalents | 9.4 | 20.0 | 35.6 | 7.1 | 22.1 | 8.0 | 7.6 | 10.2 | 8.0 | 0.3 | 0.1 |
| Short Term Investments | 0 | 0.4 | 0.9 | 0.7 | 0.4 | 0.4 | 0.8 | 2.2 | 2.5 | 3.3 | 4.6 |
| Receivables | 0.5 | 2.0 | 1.4 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 2.1 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0.8 | 3.1 | 3.9 | 1.2 | 0.5 | 0.3 | 0.3 | 0.6 | 0.4 | 0.1 | 0.1 |
| Total Current Assets | 10.7 | 25.5 | 39.1 | 9.2 | 23.0 | 8.6 | 8.5 | 12.7 | 10.9 | 3.7 | 4.9 |
| PP&E | 5.4 | 10.9 | 8.5 | 6.5 | 3.7 | 0.6 | 0.8 | 0.7 | 0.6 | 0.1 | 0.1 |
| Intangible Assets | 56.6 | 61.6 | 91.2 | 15.0 | 0 | 0 | 0.7 | 1.0 | 1.2 | 1.5 | 1.7 |
| Goodwill | 0 | 0 | 18.7 | 9.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.7 | 1.7 | 13.4 | 11.0 | 0 | 0 | 0 | 0 | 0 | (1.6) |
| Other Long Term Assets | 2.2 | 2.1 | 2.0 | 1.9 | 2.2 | 0.3 | 0.1 | 75 K | 0 | 0 | 1.6 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 74.9 | 100.1 | 159.6 | 55.4 | 39.9 | 9.5 | 10.2 | 14.4 | 12.7 | 6.4 | 8.3 |
| LIABILITIES | |||||||||||
| Accounts Payable | 1.0 | 1.3 | 1.8 | 0.4 | 0.5 | 0.2 | 0.2 | 0.4 | 0.3 | 0.1 | 0.1 |
| Short Term Debt | 1.3 | 1.6 | 3.0 | 3.2 | 1.6 | 1.6 | 1.5 | 0.4 | 0 | 5.9 | 3.0 |
| Other Current Liabilities | 4.9 | 9.2 | 9.4 | 5.3 | 2.4 | 3.8 | 2.8 | 3.4 | 2.0 | 1.4 | 1.6 |
| Total Current Liabilities | 7.2 | 12.1 | 14.1 | 9.0 | 4.4 | 5.6 | 4.5 | 4.3 | 2.3 | 7.4 | 4.7 |
| Long Term Debt | 2.2 | 2.7 | 3.5 | 5.8 | 4.6 | 0.5 | 1.4 | 0.3 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 39.9 | 51.0 | 76.7 | 7.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 49.3 | 65.8 | 94.3 | 21.9 | 9.0 | 6.1 | 5.8 | 4.6 | 2.3 | 7.4 | 4.7 |
| EQUITY | |||||||||||
| Common Stock | 310.3 | 294.9 | 253.0 | 157.2 | 124.6 | 74.7 | 60.0 | 45.8 | 34.9 | 15.1 | 15.4 |
| Retained Earnings | (289.9) | (260.7) | (187.8) | (123.7) | (93.7) | (71.3) | (54.7) | (35.3) | (24.1) | (15.4) | (10.4) |
| Other Accumulative Comprehensive Income/Loss | 49 K | 39 K | 37 K | 0 | 0 | 0 | (0.9) | (0.7) | (0.3) | (0.8) | (1.4) |
| Total Equity | 25.6 | 34.3 | 65.2 | 33.5 | 30.8 | 3.4 | 4.4 | 9.9 | 10.4 | (1.1) | 3.6 |
| Total Liabilities and Equity | 74.9 | 100.1 | 159.6 | 55.4 | 39.9 | 9.5 | 10.2 | 14.4 | 12.7 | 6.4 | 8.3 |
| SHARES OUTSTANDING | |||||||||||
| Common Shares Outstanding | 7.7 | 5.5 | 4.4 | 3.3 | 2.6 | 1.9 | 1.5 | 1.3 | 1.1 | 0.3 | 0.3 |